Does nebulized dexamethasone decrease the incidenceof postextubation sore throat?: a randomized controlled study

Objective and aim of study Postoperative sore throat (POST) is a common complaint in about 21–65% of patients undergoing general anesthesia with endotracheal intubation. The aim of this randomized controlled study was to evaluate the efficacy of preoperative nebulized dexamethasone in decreasing the incidence of postextubation sore throat.Patients and methodsA total of 120 American Society of Anesthesiologists (ASA) physical status I–II patients of both sexes aged 25–60 years sexes were included in this study. Patients were randomly assigned into one of the two groups of 60 patients each: group D received dexamethasone 8 mg in 5 ml nebulization and group S (the control group) received normal saline in 5 ml nebulization 15 min before general anesthesia and endotracheal intubation. The intensity of sore throat and hemodynamic variables were monitored before nebulization, on arrival to the postanesthesia care unit (0 h), and at 2, 4, 8, 12, and 24 h postoperatively.ResultsThe incidence and severity of POST were significantly reduced in the dexamethasone group than in the saline group at the following time intervals: 2 h after extubation (P = 0.009), 4 h after extubation (P = 0.000), 8 h after extubation (P = 0.000), and 12 h after extubation (P = 0.002). There was no complication associated with dexamethasone nebulization.ConclusionPreoperative nebulization with dexamethasone 8 mg reduces the incidence and severity ofPOST in patients receiving general anesthesia with endotracheal intubation.